Stock Analiz

Bio-rad Laboratories, Inc. (BIO) earnings: date, estimates and history

Price $366.36 · data as of November 13, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate$2.83
Revenue estimate$689M
Expected EPS growth+12.8%

The date appears here once Bio-rad Laboratories confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates3 of 4
Average surprise+20.4%
Average move on report day±5.0%

Bio-rad Laboratories beat the consensus earnings estimate in 3 of its last 4 reports, by +20.4% on average. On report days the stock moved 5.0% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
November 4, 2026
Sep/2026
$2.23$2.65+19.1%$656M+0.5%−1.6%
August 4, 2026
Jun/2026
$1.75$2.62+50.1%$651M−0.1%+3.9%
April 30, 2026
Mar/2026
$1.99$1.89−4.8%$592M+1.1%−6.8%
October 29, 2025
Sep/2025
$1.93$2.26+17.0%$653M+0.5%−7.8%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is Bio-rad Laboratories’s next earnings date?

Bio-rad Laboratories has not confirmed its next report date yet. Its last report was on November 4, 2026.

Did Bio-rad Laboratories beat earnings last quarter?

Yes, it reported EPS of $2.65 on November 4, 2026 against an estimate of $2.23 (a +19.1% surprise), and the stock moved −1.6% the next trading day.

What EPS do analysts expect next quarter?

The consensus estimate is $2.83 per share on revenue of about $689M.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar